News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
172,239 Results
Type
Article (17434)
Company Profile (16)
Press Release (154789)
Section
Business (45586)
Career Advice (565)
Deals (6790)
Drug Delivery (27)
Drug Development (23029)
Employer Resources (35)
FDA (3935)
Job Trends (3988)
News (79032)
Policy (6832)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
Academia (1776)
Accelerated approval (1)
Adcomms (12)
Allergies (16)
Alliances (13913)
ALS (22)
Alzheimer's disease (503)
Antibody-drug conjugate (ADC) (29)
Approvals (3960)
Artificial intelligence (70)
Autoimmune disease (5)
Automation (2)
Bankruptcy (43)
Best Places to Work (3428)
BIOSECURE Act (15)
Biosimilars (27)
Biotechnology (10)
Bladder cancer (20)
Brain cancer (11)
Breast cancer (82)
Cancer (665)
Cardiovascular disease (43)
Career advice (485)
Career pathing (7)
CAR-T (45)
Cell therapy (115)
Cervical cancer (11)
Clinical research (18180)
Collaboration (243)
Compensation (44)
Complete response letters (3)
COVID-19 (1114)
CRISPR (14)
C-suite (62)
Cystic fibrosis (28)
Data (623)
Denatured (2)
Depression (6)
Diabetes (60)
Diagnostics (1744)
Digital health (3)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (29)
Drug pricing (23)
Drug shortages (4)
Duchenne muscular dystrophy (17)
Earnings (11756)
Editorial (9)
Employer branding (6)
Employer resources (27)
Events (22311)
Executive appointments (157)
FDA (4260)
Featured Employer (6)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (277)
Gene editing (26)
Generative AI (3)
Gene therapy (127)
GLP-1 (152)
Government (1338)
Grass and pollen (1)
Guidances (10)
Healthcare (5515)
Huntington's disease (6)
IgA nephropathy (3)
Immunology and inflammation (30)
Indications (5)
Infectious disease (1158)
Inflammatory bowel disease (39)
Inflation Reduction Act (2)
Influenza (12)
Intellectual property (13)
Interviews (105)
IPO (3350)
IRA (12)
Job creations (725)
Job search strategy (410)
Kidney cancer (5)
Labor market (9)
Layoffs (87)
Leadership (4)
Legal (1185)
Liver cancer (24)
Lung cancer (109)
Lymphoma (42)
Machine learning (2)
Management (10)
Manufacturing (64)
MASH (14)
Medical device (2929)
Medtech (2929)
Mergers & acquisitions (3599)
Metabolic disorders (125)
Multiple sclerosis (22)
NASH (7)
Neurodegenerative disease (21)
Neuropsychiatric disorders (7)
Neuroscience (644)
NextGen: Class of 2025 (1873)
Non-profit (2018)
Northern California (575)
Now hiring (6)
Obesity (52)
Opinion (72)
Ovarian cancer (33)
Pain (29)
Pancreatic cancer (17)
Parkinson's disease (38)
Partnered (5)
Patents (34)
Patient recruitment (32)
Peanut (10)
People (16699)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase I (5633)
Phase II (8175)
Phase III (6158)
Pipeline (303)
Podcasts (13)
Policy (48)
Postmarket research (754)
Preclinical (2490)
Press Release (18)
Prostate cancer (27)
Psychedelics (10)
Radiopharmaceuticals (54)
Rare diseases (107)
Real estate (1335)
Recruiting (16)
Regulatory (4872)
Reports (10)
Research institute (1891)
Resumes & cover letters (91)
Rett syndrome (1)
RNA editing (2)
RSV (10)
Schizophrenia (18)
Series A (46)
Series B (22)
Sickle cell disease (20)
Southern California (507)
Special edition (2)
Spinal muscular atrophy (36)
Sponsored (3)
Startups (1204)
Stomach cancer (5)
Supply chain (14)
Tariffs (5)
The Weekly (11)
United States (5330)
Vaccines (235)
Venture capitalists (18)
Webinars (3)
Weight loss (38)
Women's health (4)
Worklife (3)
Date
Today (25)
Last 7 days (202)
Last 30 days (728)
Last 365 days (8737)
2025 (2093)
2024 (9128)
2023 (10576)
2022 (14004)
2021 (15321)
2020 (14402)
2019 (12940)
2018 (9760)
2017 (8756)
2016 (8804)
2015 (10233)
2014 (7596)
2013 (6140)
2012 (6250)
2011 (6486)
2010 (5521)
Location
Africa (268)
Alabama (29)
Alaska (3)
Arizona (50)
Arkansas (3)
Asia (10557)
Australia (2367)
California (1317)
Canada (407)
China (122)
Colorado (63)
Connecticut (65)
Delaware (44)
Europe (22897)
Florida (218)
Georgia (49)
Idaho (13)
Illinois (158)
India (7)
Indiana (66)
Japan (48)
Kansas (20)
Kentucky (11)
Louisiana (1)
Maine (9)
Maryland (181)
Massachusetts (922)
Michigan (43)
Minnesota (68)
Missouri (24)
Montana (6)
Nebraska (4)
Nevada (6)
New Hampshire (13)
New Jersey (528)
New Mexico (7)
New York (520)
North Carolina (183)
North Dakota (3)
Northern California (575)
Ohio (48)
Oklahoma (5)
Oregon (8)
Pennsylvania (288)
Rhode Island (8)
South America (333)
South Carolina (5)
Southern California (507)
Tennessee (31)
Texas (226)
Utah (32)
Virginia (28)
Washington D.C. (33)
Washington State (134)
West Virginia (1)
Wisconsin (9)
172,239 Results for "doheny eye institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Doheny Eye Institute Announces Upcoming Presentations at ARVO 2024 Annual Meeting
Doheny Eye Institute announced that more than 25 of its scientists and clinician-scientists will present their latest research during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, the premiere gathering for eye and vision scientists from across the globe.
April 24, 2024
·
3 min read
Press Releases
Doheny Eye Institute To Receive Funding from NIH Award Supporting Cerebral Small Vessel Disease Detection
October 3, 2024
·
6 min read
Biotech Beach
Doheny Eye Institute Announces Upcoming Presentations at ARVO 2023 Annual Meeting
Doheny Eye Institute announced that more than 30 of its scientists and clinician-scientists will present their latest research during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. The meeting will take place April 23-27, 2023 in New Orleans at the Ernest N. Morial Convention Center.
April 21, 2023
·
3 min read
Genetown
Ora and Singapore Eye Research Institute Unveil Groundbreaking Partnership to Propel Ophthalmology Innovation Globally
Ora, Inc., the foremost global ophthalmology contract research organization, announced a strategic, exclusive partnership with the Singapore Eye Research Institute, a world-renowned institution for cutting-edge eye research and ophthalmic preclinical studies.
May 2, 2024
·
6 min read
Lone Star Bio
Mann Eye Institute Unveils State-of-the-Art Office-Based Surgery Center in Austin
Mann Eye Institute announces the grand opening of its office-based surgery center, Mann Austin Surgery Center, at 4314 W. Braker Lane, Suite #215, Austin, TX 78759.
June 26, 2024
·
2 min read
Business
Doheny Eye Institute Announces the Appointment of Deborah Ferrington, PhD as Chief Scientific Officer
Doheny Eye Institute, a global leader in vision research and basic science to save human eyesight, has announced that Deborah Ferrington, PhD, is joining the organization as Chief Scientific Officer.
January 12, 2022
·
2 min read
GLP-1
EMA to Investigate Eye Risk for Novo’s Ozempic: Reuters
Following an appeal by the Danish Medicines Agency, the European Union’s drug regulator will review two new studies that have strengthened the link between Novo Nordisk’s blockbuster GLP-1 and a rare eye disease.
December 18, 2024
·
2 min read
·
Annalee Armstrong
NextGen
Delphia Eyes New Precision Medicine Approach: Activation Lethality
Delphia launched in May 2024 with the goal of forcing malignant cells to overactivate and die.
March 4, 2025
·
2 min read
·
Annalee Armstrong
Layoffs
Carisma Lays Off Most of Staff, Eyes Sale of Assets and Company
Cell therapy and oncology–focused Carisma Therapeutics started layoffs late last year. Now the company plans to wind down fully.
April 1, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
IVIEW Therapeutics Announces Topline Results from Phase 1/2 Trial of IVW-1001 Ophthalmic Eyelid Wipe for Dry Eye Disease
February 10, 2025
·
3 min read
1 of 17,224
Next
